Cafepharma Today

February 15 2019 - Medicare would cover CAR-T under new CMS proposal
Medicare would cover CAR-T under new CMS proposal
Biopharma and climate change
Bayer acquires full Vitrakvi rights from Lilly’s Loxo
A record year for device innovation
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

NEW board: Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience. Read the latest answer -- about employment agreements under Chapter 11.

Today's most popular searches:

Current News

submit a press release
World Health Organization Forms Committee To Guide Editing Of Human Genes
NPR
Saturday, February 16, 2019 - 12:16am
tags:
WHO, CRISPR, gene editing
Teva set to shed 11 manufacturing sites in 2019
BioPharma Dive
Saturday, February 16, 2019 - 12:09am
tags:
Teva Pharmaceutical, drug manufacturing
Insys Founder’s Protege Was ‘Fall Guy’ When Opioid Plan Faltered
Bloomberg
Saturday, February 16, 2019 - 12:07am
tags:
INSYS Therapeutics, John Kapoor, Michael Babich, rackateering
NICE backs Takeda’s Alunbrig in second-line lung cancer
Pharmaforum
Saturday, February 16, 2019 - 12:02am
tags:
NICE, Takeda, Alunbrig, ALK-positive non-small cell lung cancer
Report: FDA panel wants more extensive data, quality of life outcomes for vaginal mesh products
Mass Device
Saturday, February 16, 2019 - 12:01am
tags:
FDA, devices, transvaginal mesh, pelvic mesh
Pharmacy Fraud Within Pharmaceutical Co-Pay Programs: What You Need To Know
Drug Channels
Friday, February 15, 2019 - 11:59pm
tags:
co-pay cards, fraud
These medtech companies raised the most VC in 2018
Mass Device
Friday, February 15, 2019 - 11:57pm
tags:
devices, venture capital
Medicare would cover CAR-T cell therapies under new CMS proposal
Marketwatch
Friday, February 15, 2019 - 12:22pm
tags:
Medicare, CAR-T, cell therapy, CMS, Novartis, Kymriah, Gilead Sciences, Yescarta
FDA funding set to jump as Congress votes to avert shutdown
Fierce Biotech
Friday, February 15, 2019 - 11:52am
tags:
FDA, congress
Keytruda-Inlyta combo under Priority Review for first-line RCC
BioCentury
Friday, February 15, 2019 - 10:34am
tags:
Merck, Keytruda, Inlyta, renal cell carcinoma, FDA, priority review
Hurricanes, droughts, and wildfires: How biopharma is girding for climate change
Stat
Friday, February 15, 2019 - 10:29am
tags:
climate change, natural disasters, tropical diseases, Takeda, AbbVie, Roche
Bayer acquires full Vitrakvi rights from Eli Lilly's Loxo
Yahoo/Reuters
Friday, February 15, 2019 - 10:27am
tags:
Bayer, Vitrakvi, cancer, Eli Lilly, Loxo Oncology
Bayer stresses drug's tolerability in bid for prostate cancer market
Yahoo/Reuters
Friday, February 15, 2019 - 10:25am
tags:
Bayer, prostate cancer, darolutamide, Pfizer, JNJ
Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride
Pharmaceutical Business Review
Friday, February 15, 2019 - 10:13am
tags:
Boehringer Ingelheim, Eli Lilly, glimepiride, linagliptin, Tradjenta, type 2 diabetes, clinical trials
Stealth Bio prices $78M IPO at bottom end of range
BioCentury
Friday, February 15, 2019 - 10:12am
tags:
Stealth BioTherapeutics, IPOs, mitochondrial disorders
A record year for device innovation
Mass Device
Friday, February 15, 2019 - 10:10am
tags:
FDA, devices, innovation
Merck plans trio of Phase 3 Keytruda studies in prostate cancer
BioPharma Dive
Thursday, February 14, 2019 - 5:56pm
tags:
Merck, Keytruda, prostate cancer, clinical trials
Liver toxicity concerns spike Motif Bio’s iclaprim filing
Fierce Biotech
Thursday, February 14, 2019 - 5:55pm
tags:
FDA, Motif Biosciences, ABSSSI, Iclaprim, complete response letter
Study: Patent Term Restoration Extends Drug Patents by About 3 Years
RAPS.org
Thursday, February 14, 2019 - 5:53pm
tags:
patents, patent term restoration, market exclusivity
Drugmakers Debate Whether Parts of FDA’s Biosimilar Guidance are Unconstitutional
RAPS.org
Thursday, February 14, 2019 - 5:46pm
tags:
FDA, biosimilars, BLA, NDA

Pages

Latest CP Wire Articles

5AM Raises $500 Million for Two Life Science Funds
Company with NASH Candidate in Ph IIb Trials Updates $86 Million IPO filing
Ascletis Acquires Rights to PH II NASH Candidate
Microbiome Report for Week Ending 2/9/19
China to Cut Value Added Tax on Rare Disease Drugs to 3%
Sorrento and Yuhan Secure $40 Million for Immuno-Oncology Joint Venture
Xeris Announces $84 Million Offering
Seattle Genetics Hits $30 Million Milestone With European Approval of Adcetris in Frontline Hodgkin Lymphoma
Shockwave Medical Plans IPO
Investigational Live Microbial Drug Granted Breakthrough Therapy Designation for Recurrent C. Difficile

Latest Pharmagather Articles

Patient Communications: Why Pharma Leaders Should Think Like Social Marketers
pharmexec marketing
India’s Disgrace
In the Pipeline
Pharmacy Fraud Within Pharmaceutical Co-Pay Programs: What You Need To Know
Drug Channels
Odd Peroxides Indeed
In the Pipeline
Preorder Now: Our 2019 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
Drug Channels
Vibrating Proteins, Resolved
In the Pipeline
The FDA and the Dietary Supplements
In the Pipeline
Express Scripts Confirms It (Again): Minimal Growth in Drug Spending and Prescription Costs
Drug Channels
Virtual Screening – As Big As It Currently Gets
In the Pipeline
Pharma Jobs from Indeed


Pharma and Device News from NASDAQ

Myriad Applauds the American Society of Breast Surgeons New Guidelines Recommending Genetic Testing for All People with Breast Cancer
Friday, February 15, 2019 - 7:05am
H-ISAC ANNOUNCES PARTNERSHIP IN JAPAN
Thursday, February 14, 2019 - 10:56am
Adverum to Present at the 8th Annual SVB Leerink Global Healthcare Conference
Wednesday, February 13, 2019 - 4:10pm
Healthcare safety consortium extends ISA cybersecurity standards to connected medical devices
Wednesday, February 13, 2019 - 9:00am
MacroGenics to Participate in Guggenheim Healthcare Talks Idea Forum
Wednesday, February 13, 2019 - 8:00am
MacroGenics Announces Pricing of Public Offering of Common Stock
Tuesday, February 12, 2019 - 9:25pm
MacroGenics Announces Proposed Public Offering of Common Stock
Tuesday, February 12, 2019 - 4:01pm
Researchers at Queen’s University Belfast have Developed a Vaginal Ring Capable of Providing Sustained Delivery of OB-002 (5P12-RANTES) for HIV Prevention
Tuesday, February 12, 2019 - 9:00am
PROVECTUS ANNOUNCES GRANT OF ORPHAN DRUG DESIGNATION IN U.S. TO PV-10 FOR TREATMENT OF OCULAR MELANOMA
Tuesday, February 12, 2019 - 7:30am
Adverum Biotechnologies Announces Presentation of Preclinical Long-Term Safety Data of ADVM-022 at 2019 Angiogenesis, Exudation, and Degeneration Conference
Monday, February 11, 2019 - 8:30am

Breaking Healthcare News - powered by Seeking Alpha

Early-stage study of Denali's Alzheimer's candidate DNL747 underway; shares up 1% premarket
Friday, February 15, 2019 - 9:18am
CannAmerica signs LOI with Winchester
Friday, February 15, 2019 - 8:54am
CymaBay +11% on receiving breakthrough therapy designation for Seladelpar
Friday, February 15, 2019 - 8:51am
Pot stocks in the green premarket
Friday, February 15, 2019 - 8:43am
Nevro sues Stimwave Technologies for patent infringement
Friday, February 15, 2019 - 8:17am
Hoth Therapeutics prices IPO at $5.60
Friday, February 15, 2019 - 8:08am
Key events next week - healthcare
Friday, February 15, 2019 - 8:02am
Raymond James bullish on Teva after Q4 report
Thursday, February 14, 2019 - 9:32am
Alkermes Q4 top line up 15%
Thursday, February 14, 2019 - 9:24am
Medigus mulling entry into medical cannabis arena; shares up 10% premarket
Thursday, February 14, 2019 - 9:20am

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.